Literature review reveals gaps in epidemiology and treatment care in multiple myeloma patients in LATAM, suggesting disparities in clinical outcomes and access to care.
Key Points
Clinical outcomes were highly variable in Latin America, reflecting disparities between public and private healthcare settings.
Of 878 reviewed articles, only 40 focused on multiple myeloma, highlighting gaps in the literature regarding treatment options and epidemiology.
Treatment patterns in multiple myeloma displayed significant differences across LATAM countries, particularly in access to newer medications like daratumumab.
Adverse events related to treatments were inconsistently reported, indicating a need for better data collection and reporting in future studies.